Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism

J Neural Transm Suppl. 1990:32:269-75. doi: 10.1007/978-3-7091-9113-2_37.

Abstract

Mongolian gerbils of both sexes received a single daily dose of 40 mg/kg of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) over 4 consecutive days. On the fifth day the animals were treated with 15 mg/kg i.p. of L-deprenyl or amantadine or the combination of both drugs. At different time intervals (1, 2, 5 hours) the animals were sacrificed. In the caudate nuclei dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were measured by an HPLC technique. MPTP affected the dopaminergic (HVA -25%) as well as the serotoninergic system (5-HT -54%, 5-HIAA -31%). L-deprenyl and amantadine accumulated DA and 5-HT in the MPTP affected caudates. Synergistic effects of the drug combination could be proven.

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine*
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Amantadine / pharmacology*
  • Animals
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / metabolism
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dopamine / metabolism
  • Drug Interactions
  • Female
  • Gerbillinae
  • Homovanillic Acid / metabolism
  • Hydroxyindoleacetic Acid / metabolism
  • Male
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / drug therapy*
  • Selegiline / pharmacology*
  • Serotonin / metabolism

Substances

  • 3,4-Dihydroxyphenylacetic Acid
  • Selegiline
  • Serotonin
  • Hydroxyindoleacetic Acid
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Amantadine
  • Dopamine
  • Homovanillic Acid